Buscar
01/11/2021
Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population
Camps-Vilaro, A, Perez-Fernandez, S, Subirana, I, Teira, R, Estrada, V, Domingo, P, Degano, IR, Marrugat, J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11)DOI:10.3390/jpm11111085. PMID:34834438. IF:3.508(Q2/4D).
01/11/2021
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Llibre, JM, Domingo, P, Falco, V, Imaz, A, Cortes, C, Force, L, Letang, E, Vilaro, I, Casabona, J, Miro, JM, Mur I., Macorigh, Lizza. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11)DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16.070(Q1/1D).
01/10/2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year period
Kowalska, JD, Pelchen-Matthews, A, Ryom, L, Losso, MH, Trofimova, T, Mitsura, VM, Khromova, I, Paduta, D, Stephan, C, Domingo, P, Bakowska, E, Monforte, AD, Oestergaard, L, Jablonowska, E, Kuznetsova, A, Moreno, S, Vasylyev, M, Pradier, C, Battegay, M, Vandekerckhove, L, Castagna, A, Raben, D, Mocroft, A, EuroSIDA Study Grp. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12)DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4.632(Q2/5D).
24/09/2021
Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study
Arroyo-Diaz, JA, Julve, J, Vlacho, B, Corcoy, R, Ponte, P, Roman, E, Navas-Mendez, E, Llaurado, G, Franch-Nadal, J, Domingo, P, Mauricio, D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6.461(Q1/2D).
02/09/2021
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R, Diaz-Cuervo, H, Aragao, F, Munoz, J, Galindo, P, Merino, M, de la Fuente, B, Sepulveda, MA, Domingo, P, Garcia, J, Castano, M, Ribera, E, Geijo, P, Romero, A, Peraire, J, Deig, E, Roca, B, Martinez, E, Estrada, V, Montero, M, Berenguer, J, Espinosa, N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3)DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1.676(Q4/9D).
01/09/2021
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Gonzalez-Cordon, A, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, HJ, Guaraldi, G, Masia, M, Gompels, M, De Wit, S, Florence, E, Esser, S, Raffi, F, Behrens, G, Pozniak, A, Gatell, JM, Martinez, E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9)DOI:10.1093/jac/dkab158. PMID:34120186. IF:5.758(Q1/2D).
28/08/2021
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review
Palacio-Vieira, J, Reyes-Uruena, JM, Imaz, A, Bruguera, A, Force, L, Llaveria, AO, Llibre, JM, Vilaro, I, Borras, FH, Falco, V, Riera, M, Domingo, P, de Lazzari, E, Miro, JM, Casabona, J, Gurgui M., Hernandez, J.. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1)DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4.135(Q2/4D).
01/08/2021
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial
Rojas, J, de Lazzari, E, Negredo, E, Domingo, P, Tiraboschi, J, Ribera, E, Abdulghani, N, Puig, J, Mateo, MG, Podzamczer, D, Gutierrez, MM, Paredes, R, Clotet, B, Gatell, JM, Blanco, JL, Martinez, E, DOLAM Study Grp. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8)DOI:10.1016/S2352-3018(21)00100-4. PMID:34358497. IF:16.070(Q1/1D).
01/07/2021
Not all COVID-19 pandemic waves are alike
Domingo, P, Pomar, V, Mur, I, Castellvi, I, Corominas, H, de Benito, N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7)DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13.310(Q1/1D).
31/12/2022
Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy
Domingo, P, Giralt, M, Gavalda-Navarro, A, Blasco-Roset, A, Delgado-Angles, A, Gallego-Escuredo, JM, Gutierrez, MD, Mateo, MG, Cereijo, R, Domingo, JC, Villarroya, F, Villarroya, J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. Adipocyte. 2022; 11(1)DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3.300(Q3/6D).
19/10/2022
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
Llaurado, G, Vlacho, B, Wargny, M, Ruan, Y, Franch-Nadal, J, Domingo, P, Gourdy, P, Saulnier, PJ, Hadjadj, S, Wild, SH, Rea, R, Cariou, B, Khunti, K, Mauricio, D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9.300(Q1/1D).
14/09/2022
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
Spinner, CD, Felizarta, F, Rizzardini, G, Philibert, P, Mitha, E, Domingo, P, Stephan, CJ, DeGrosky, M, Bainbridge, V, Zhan, J, Dumitrescu, TP, Jeffrey, JL, Xu, JF, Halliday, F, Gan, JJ, Johnson, M, Gartland, M, Joshi, SR, Lataillade, M. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5)DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11.800(Q1/1D).
08/08/2022
Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study
Castellvi, I, Castillo, D, Corominas, H, Mariscal, A, Orozco, S, Benito, N, Pomar, V, Baucells, A, Mur, I, de la Rosa-Carrillo, D, Lobo, D, Millan, AM, de Sosa, NH, Filella, D, Matas, L, Martinez-Martinez, L, Juarez, C, Casademont, J, Domingo, P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3.900(Q2/4D).
01/08/2022
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
Masip, J, Jorba, R, Lopez-Dupla, M, Domingo, P, Pacheco, YM, Garcia-Pardo, G, Martinez, E, Vilades, C, Veloso, S, Alba, V, Olona, M, Vidal, F, Gomez-Bertomeu, F, Peraire, J, Rull, A. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158071. PMID:35897644. IF:5.600(Q1/3D).
28/07/2022
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study
Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Casabona, J, Domingo, P, Navarro, J, Imaz, A, Deig, E, Navarro, G, Llibre, JM, Miro, JM. Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(8)DOI:10.1093/jac/dkac177. PMID:35678461. IF:5.200(Q1/3D).
01/07/2022
Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT
Franquet, T, Gimenez, A, Ketai, L, Mazzini, S, Rial, A, Pomar, V, Domingo, P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7)DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5.900(Q1/2D).
29/06/2022
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).
27/06/2022
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Moga, E, Lynton-Pons, E, Domingo, P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7.300(Q1/3D).
01/05/2022
Pulmonary Infections in People Living with HIV
Franquet, T, Domingo, P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3)DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1.900(Q3/8D).
01/03/2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).
17/02/2022
Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity
Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).
01/02/2022
Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy
Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).
01/02/2022
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).
27/01/2022
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
Collazos, J, Domingo, P, Fernandez-Araujo, N, Asensi-Diaz, E, Vilchez-Rueda, H, Lalueza, A, Roy-Vallejo, E, Blanes, R, Raya-Cruz, M, Sanz-Canovas, J, Artero, A, Ramos-Rincon, JM, Duenas-Gutierrez, C, Lamas-Ferreiro, JL, Asensi, V. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1)DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3.700(Q2/4D).
01/12/2021
Alpha variant SARS-CoV-2 infection: How it all starts
Domingo, P, de Benito, N. Alpha variant SARS-CoV-2 infection: How it all starts. EBioMedicine. 2021; 74DOI:10.1016/j.ebiom.2021.103703. PMID:34800902. IF:11.205(Q1/2D).
01/11/2025
Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain
Camps-Vilaró, A, Teira, R, Subirana, I, Dégano, IR, Domingo, P, Curran, A, Montero-Alonso, M, Romero, A, Marrugat, J, Galindo, MJ. Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2025; 160DOI:10.1016/j.ijid.2025.108061. PMID:40953693. IF:4.300(Q1/2D).
01/08/2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
de Lazzari, E, Di Gregorio, S, Rojas, J, Curran, A, Domingo, P, Negredo, E, Tiraboschi, J, Gonzalez-Cordon, A, Torres, B, Sempere, A, Inciarte, A, Gatell, JM, Blanco, JL, Martinez, E. 48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(8)DOI:10.1093/jac/dkaf192. PMID:40556520. IF:3.600(Q2/3D).
08/07/2025
Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions
Giralt, M, Domingo, P, Quesada-López, T, Cereijo, R, Villarroya, F. Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(14)DOI:10.3390/ijms26146546. PMID:40724797. IF:4.900(Q1/3D).
01/07/2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Esteban, H, Gil, P, de Miguel, M, Alejos, B, Martínez, E. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV. 2025; 12(7)DOI:10.1016/S2352-3018(25)00105-5. PMID:40489982. IF:13.000(Q1/1D).
01/04/2025
Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial
Rogg, L, Nuñez, SA, Mingrone, MVO, Domingo, P, Lopez, M, Hanan, N, Ghita, GL, Jeffrey, JL, Underwood, M, Castillo-Mancilla, JR, Halliday, F, Ezeadi, E, Gartland, M. Antiviral effect, safety, and tolerability of the third-generation integrase strand transfer inhibitor VH4524184 (VH-184): a proof-of-concept trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).
04/03/2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
Bailón, L, Moltó, J, Curran, A, Cadiñanos, J, de Quirós, JCLB, de los Santos, I, Ambrosioni, J, Imaz, A, Benet, S, Suanzes, P, Navarro, J, González-García, J, Busca, C, Pérez-Latorre, L, Berenguer, J, García-Fraile, LJ, Mejia-Abril, G, Miró, JM, Scévola, S, Moreno, S, Domingo, P, Tian, Y, Frankot, M, Lim, D, Cai, YH, Vendrame, E, Guo, S, Wallin, JJ, Geleziunas, R, Sengupta, D, Alarcón-Soto, Y, Leal, I, Aranguen, A, Garcia-Garcia, M, McGowan, I, Brander, C, Arribas, JR, Mothe, B. Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-57284-w. PMID:40038256. IF:15.700(Q1/1D).
01/02/2025
Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019
Suades, R, Greco, MF, Padró, T, de Santisteban, V, Domingo, P, Benincasa, G, Napoli, C, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood CD45+/CD3+ lymphocyte-released extracellular vesicles and mortality in hospitalized patients with coronavirus disease 2019. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2025; 55(2)DOI:10.1111/eci.14354. PMID:39548690. IF:3.600(Q1/2D).
01/01/2025
Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands
Bruguera, A, Nomah, DK, Moreno-Fornés, S, Martinez, E, Negredo, E, Tiraboschi, J, Navarro, J, Domingo, P, Fanjul, F, Villoslada, A, Peraire, J, Jaen, A, Miró JM, Casabona, J, Reyes-Urueña, J. Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands. AIDS. 2025; 39(1)DOI:10.1097/QAD.0000000000004018. PMID:39639721. IF:3.100(Q2/4D).
01/12/2024
The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study
Pan Y.-H., Nomah D.K., Montoro-Fernandez M., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Llibre J.M., Domingo P., Imaz A., Vilaró I., Falcó V., Reyes-Urueña J., Miro J.M., Casabona J.. The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(10)DOI:10.1016/j.eimc.2023.09.001. PMID:38218704. IF:2.500(Q2/5D).
01/10/2024
Prediction of COVID-19 severity using machine learning
Karaduzovic-Hadziabdic, K, Adilovic, M, Zhang, L, Lumley, A, Shah, PA, Shoaib, M, Satagopam, V, Srivastava, PK, Emanueli, C, Greco, S, Made, A, Padro, T, Domingo, P, Lustrek, M, Scholz, M, Rosolowski, M, Jordan, M, Benczik, B, Agg, B, Ferdinandy, P, Baker, AH, Fagherazzi, G, Ollert, M, Michel, J, Sanchez, G, Firat, H, Brandenburger, T, Martelli, F, Badimon, L, Devaux, Y. Prediction of COVID-19 severity using machine learning. Clinical and Translational Medicine. 2024; 14(10)DOI:10.1002/ctm2.70042. PMID:39370709. IF:6.800(Q1/2D).
01/10/2024
The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7
Díaz, M, Quesada, T, Villarroya, F, López-Bermejo, A, Casano, P, De Zegher, F, Ibanez, L. The proteome of circulating exosomes in appropriate- versus small-for-gestational-age infants: differentially expressed proteins at birth associate with measures of weight gain, liver fat, insulin resistance and adrenarche at age 7. Hormone Research in Paediatrics. 2024; 97DOI:. PMID:. IF:2.700(Q1/2D).
01/07/2024
CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection
Suades, R, Greco, MF, Prieto, P, Padro, T, Devaux, Y, Domingo, P, Badimon, L. CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection. Journal of Extracellular Vesicles. 2024; 13(7)DOI:10.1002/jev2.12456. PMID:39007437. IF:14.500(Q1/1D).
01/07/2024
Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial
Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial. Journal of the International AIDS Society. 2024; 27DOI:. PMID:. IF:4.900(Q1/2D).
01/06/2024
Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients
Suades, R, Padró, T, Domingo, P, Greco, MF, Benincasa, G, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/04/2024
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV
Berenguer, J, Jarrín, I, Bellón, JM, Díez, C, Jiménez-Sousa, MA, López, JC, Pinto-Martínez, A, Moreno, S, Montes, ML, Iribarren, JA, Orviz, E, Portilla, J, Villarroya, F, Domingo, P, Resino, S. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. JOURNAL OF INFECTIOUS DISEASES. 2024; 230(2)DOI:10.1093/infdis/jiae168. PMID:38557859. IF:4.500(Q1/2D).